We have identified the homologous gene family (Rbm) on the mouse Y with a view to investigating the proposal that this gene family plays a role in spermatogenesis. At least 25 and probably >50 copies of Rbm are present on the mouse Y chromosome short arm located between Sry and the centromere. As in the human, a role in spermatogenesis is indicated by a germ cell-specific pattern of expression in the testis, but there are distinct differences in the pattern of expression between the two species. Mice carrying the deletion Y d1 , that maps to the proximal Y short arm, are female due to a position effect resulting in non-expression of Sry; sex-reversing such mice with an Sry transgene produces males with a high incidence of abnormal sperm, making this the third deletion interval on the mouse Y that affects some aspect of spermatogenesis. Most of the copies of Rbm map to this deletion interval, and the Y d1 males have markedly reduced Rbm expression, suggesting that RBM deficiency may be responsible for, or contribute to, the abnormal sperm development. In man, deletion of the functional copies of RBM is associated with meiotic arrest rather than sperm anomalies; however, the different effects of deletion are consistent with the differences in expression between the two species.
INTRODUCTION
The mammalian Y chromosome, although once widely assumed to be devoid of genes other than the testis determinant, now has a steadily increasing list of genes to its credit. In man, several of these genes have closely related X homologues which are not X-inactivated (1, 2) and may simply function to equalize the expressed dose in males and females. However, Y chromosome deletion mapping has assigned essential spermatogenic functions to specific regions of the human and mouse Y chromosomes (3, 4) ; with respect to the human Y, deletions covering the region Yq11 are associated with spermatogenic failure, thus defining a Y-linked azoospermia factor (AZF). More detailed mapping of this region using molecular markers identified a series of microdeletions in infertile men with cytologically normal Y chromosomes (5) (6) (7) (8) , and this led to the mapping of members of two RNA-binding motif gene families to the AZF deletion interval. The first to be identified and proposed as a candidate for AZF was the RBM (formerly YRRM) family; RBM is expressed in the testis, and deletions removing some of the gene copies are associated with male sterility (9) (10) (11) (12) (13) (14) (15) . The second AZF candidate gene, DAZ, is also transcribed in the testis and encodes a protein with an RNA-binding motif (8) . Initially thought to be single copy, it is now clear that DAZ is also represented by more than one related copy on the Y chromosome (14, 16 On 'zooblots', RBM-related genes appear to be present on the Y chromosome of most mammals, including the marsupial Y (9, 17) . In the mouse, hybridization to an ∼6 kb EcoRI fragment was taken to indicate the presence of a single copy gene (9) , raising the possibility of targeted mutagenesis of the mouse locus. However, we now know that the mouse Rbm locus is also present in multiple copies, all of which map to the mouse Y short arm between Sry and the centromere (18, 19) . Here we provide further details of the genomic organization of the locus, cDNA sequence information and detailed expression data, and we describe the consequences of a deletion removing most copies of Rbm. The results provide strong support for the view that the Rbm/RBM gene family plays a role in the spermatogenic process
RESULTS

Mouse Rbm is a component of the Sx1 repeat
Three mouse Rbm-positive λ genomic clones were identified by screening a mouse genomic library with the human RBM cDNA MK5. All three clones contained an ∼6.5 kb MK5-positive EcoRI fragment, while two also contained an ∼3 kb MK5-positive EcoRI fragment (Fig. 1A) . The 6.5 kb fragment, when used to probe a 'mouse Y mapping blot' of various EcoRI-digested mouse genomic DNAs (see Fig. 1B for summary of deletion variants), hybridized in a Y-specific fashion to the ∼6 kb band (=6.5 kb) originally identified with the human RBM cDNA probe (Fig. 1C) . However, hybridization intensity varied markedly between genotypes in a manner reminiscent of the hybridization with the probe pSx1 to a multiple copy 2.6 kb EcoRI fragment (20) , raising the possibility that Rbm sequences were part of the same repeating unit. This 2.6 kb fragment has been mapped to the proximal short arm of the mouse Y (21) . The filter was therefore reprobed with pSx1 and the variation in hybridization to the 2.6 kb EcoRI fragment was almost indistinguishable from that obtained with Rbm (Fig. 1C) . Probing digests of the λ clones revealed that they contain a pSx1-hybridizing fragment. In λ7 it is an incomplete 1.3 kb SalI-EcoRI fragment, but in λ8 and λ11 the complete 2.6 kb EcoRI fragment is present (Fig. 1A) . Recently, Navin et al. (22) estimated that there are at least 50 copies of the 2.6 kb Sx1 repeat unit in normal male mice, so it is likely that Rbm is similarly repeated (see below).
Variation between genomic copies and their organization
We have also used the 3 kb MK5-positive fragment to probe the 'mouse Y mapping blot'. This gave a more complex pattern, hybridizing to an ∼1.4 kb fragment in males and females, and to Y-specific ∼1.9, ∼3 and ∼4.2 kb fragments which showed dosage differences between the genotypes (not shown). We subsequently found that these Y-specific fragments are also detected by an Rbm cDNA (see next section, Fig. 3A) , suggesting that the 4.2, 3 and 1.9 kb fragments are restriction fragment length variants (RFLVs) represented among the >50 copies of Rbm. The 4.2 kb (but not the 3 kb) fragment hybridizes to a probe, LSM15 (18) , that derives from the 1.2 kb EcoRI fragment adjacent to the 3 kb fragment in λ7; this RFLV is therefore explained by the loss of the intervening EcoRI site (E* in Fig. 1A ).
Since probe LSM15 detects the 1.2 kb fragment adjacent to the 3 kb fragment and also the 4.2 kb fragment, we used it to investigate the number of Rbm copies and RFLV type further in mouse Y deletion variants (see Materials and Methods). Figure 2A shows RFLV copies from the Y, and these must be the most proximal copies. In Figure 2B , it is assumed that the distal location of the copies with the EcoRI -RFLV seen in Sxr a is a feature of musculus-type Y chromosomes, and hence that the copies with the larger EcoRI fragments must be internal to the other copies.
The results of Phosphorimager analysis are given in Figure 2C . Using the minimum estimate of two copies of the Rbm/Sx1 repeat in Y d1 , we estimated that there are 25 copies on Y RIII . However, if Navin et al. ' s estimate of at least 50 copies is true for Y RIII , then Y d1 has at least four copies. One feature of the quantitation apparent on three independent blots is that Sxr a has fewer copies of Sx1 relative to Rbm than the other genotypes; this suggests that the original event that generated Sxr a was associated with the loss of more copies of Sx1 than of Rbm.
Mouse Rbm cDNAs
Sixteen independent Rbm cDNA clones were obtained by screening a pre-pubertal testis cDNA library with a 159 bp PCR product (see Materials and Methods) amplified from testis cDNA; from sequence comparison with the human cDNA MK5, this PCR product was known to derive from the RNA-binding domain. Automated sequencing of the 5′ and 3′ ends established that 14 of the cDNAs had both ends of the open reading frame (ORF) predicted from MK5. All 14 of these cDNAs produced a protein of the expected size when translated in vitro, indicating that they all had an intact ORF (not shown). One of the cDNAs, when hybridized to the 'Y mapping blot' (Fig. 3A) , detected EcoRI fragments of 6.5, 4.2, 3, 1.9 and 0.8 kb. The 6.5, 3 and 0.8 kb fragments are present in EcoRI digests of λ7 (Fig. 1A) . The 4.2 and 1.9 kb fragments are not present in λ7 (or in our other two λ clones), but were detected on Southern blots probed with the 3 kb EcoRI fragment from this clone, and must represent RFLVs (see above).
The longest cDNA (#8) was fully sequenced (EMBL Y15131 MMRBM) and the sequence within the ORF was found to be 99% identical to another recently reported mouse Rbm cDNA (GenBank MMU36929); the differences could reflect the fact that cDNA 8 originates from a M.musculus (RIII strain) Y chromosome whereas the cDNA of Elliot et al. (19) is of M.domesticus Y chromosomal origin (CD-1 strain). A C in place of a T at C position 244 in the CD-1 sequence introduces a PstI site. By utilizing PCR primers to amplify across this site in testis cDNA from RIII (musculus) and AKR (domesticus), and then digesting with PstI, we have shown that this site is absent from RIII transcripts but is present in most, if not all, AKR transcripts. Thus, at least for this site, it appears that we are dealing with a strain difference (probably a musculus/domesticus difference), rather than a difference arising from sampling different copies of this multiple copy gene. Despite the close similarity within the ORF, the two cDNAs differed to some extent in both the 3′-and 5′-untranslated regions. The major difference in the 5′ end was the presence of a 151 bp insert in cDNA 8 as compared with the CD-1 cDNA. The predicted proteins encoded by the two mouse cDNAs are compared with that of the human in Figure 3B . Comparison of the mouse and human proteins is discussed in detail by Elliot et al. (19) . The RNA-binding domain is highly conserved, but there is less homology outside this region. In the figure, we have drawn attention to the fact that the 37 amino acid 'SRGY box' repeat of the human RBM protein divides into two subrepeats (a and b) each ending in SRGY or variants thereof. Mouse RBM has only one copy of SRGY due to the presence of one copy of the b subrepeat; in human hnRNPG, which is the hnRNPG most closely related to RBM, this region is represented by a 'b-a-b' subrepeat structure-a feature that was overlooked by Elliot et al. (19) . The RIII strain RBM sequence differs from the published CD-1 strain sequence by seven amino acids.
In an attempt to obtain evidence for transcription from more than one genomic copy of Rbm, manual sequence data were obtained towards the 3′ end (bp 1266-1510 or 1477-1655) of the 13 unsequenced clones and all were found to be identical to cDNA 8, and different from the published CD-1 sequence. Sequencing from the 5′ end of four of these cDNAs revealed a 
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number of differences. First, they all lack the same 151 bp that are missing from the CD-1 cDNA. By using a primer specific to this 151 bp region, we have checked all the remaining cDNAs and they failed to amplify with this primer. Nevertheless, cDNA from normal males did amplify, indicating that cDNA 8 is not a cloning artefact. By using forward and reverse primers within this 151 bp stretch to obtain flanking genomic sequence from λ clone 7, we found that this 151 bp sequence is flanked by consensus splice sites. Two of the other cDNAs (10 and 17) included some sequence close to the 5′ end that is not present in cDNA 8.
Expression analysis
The adult tissue distribution of Rbm transcripts was assayed initially by RT-PCR . This only detected appreciable transcription in testis; no transcripts were detected in adult XXSxr b testes which lack germ cells, raising the possibility that Rbm expression is restricted to spermatogenic cells (Fig. 4A ). An analysis of purified testis cell populations is shown in Figure 4B . Rbm transcripts are abundant in spermatogonia, and, in common with other mouse X and Y genes analysed, are markedly reduced or absent in pachytene spermatocytes where the X and Y are condensed to form the heterochromatic sex body ('sex vesicle'). However, transcript levels return to high levels in round spermatids, showing that transcription is resumed. The changes in Rbm transcript levels for the whole testis from birth to adult ( Fig. 4C and D) reflect this pattern of expression in the germ line. From birth to 14.5 days, there is a steady increase in transcript levels as spermatogonia proliferate, then a marked drop occurs as large numbers of non-transcribing pachytene spermatocytes appear, but by 21.5 days the appearance of transcribing round spermatids stems the fall. This is very similar to the pattern of transcription for Ube1y (23) .
Because Rbm transcripts are already present on the day of birth, we looked for transcripts in the fetal testis. Transcripts are detectable by RT-PCR from the earliest age (11.5 dpc) analysed (Fig. 4E) . Fetal homozygous W e testes, which are severely depleted of germ cells, have markedly reduced levels of Rbm transcripts, suggesting that transcription in the fetal testis may also be germ cell dependent.
The consequences of a deletion removing the majority of Rbm copies
Three genotypes with markedly reduced copies of Rbm were seen in the 'mapping blot' (Fig. 1C) , which potentially could have phenotypic effects attributable to decreased Rbm function. The Y d1 deletion is potentially the most informative, because deletion of multiple copies of the Rbm/Sx1 repeat unit has occurred, while leaving the remainder of the Y chromosome intact (18, 20) .
Sex reversal
The most dramatic phenotypic effect associated with the Y d1 deletion is sex reversal, which is a consequence of a near absence of Sry transcripts in the developing gonads (18, 20) . It has been argued that Sry transcription has been inhibited by a 'position effect', the deletion having brought Sry into a region of transcriptional repression (perhaps associated with proximity to the centromere). However, the fact that the Rbm gene family is actively transcribed from this region in normal males, together with the observation that Y d1 -derived Sry transcripts are abundant in adult XYY d1 testes (18) , led us to question this explanationmight the paucity of Sry transcripts in embryonic XY d1 gonads be a consequence of reduced Rbm activity? RBM protein might, for example, be needed to stabilize the Sry transcript. To test this possibility, we produced XY d1 Y tdym1 mice to determine whether the intact Rbm region on the Sry-negative Y tdym1 chromosome [that carries a 14 kb deletion that has removed Sry (24)] would restore the testis-determining activity of the copy of Sry on the Y d1 chromosome. Eight mice of this genotype were produced, and all developed as females. We conclude that the presence in trans of a full complement of Rbm genes (and of anything else encompassed by the Y d1 deletion) does not correct the sex reversal. This strengthens the view that the sex reversal is a consequence of a position effect that interferes with Sry transcription in the fetal gonad.
Rbm expression and spermatogenesis in Y d1 males
The starting point for this project was the suggestion that the human RBM gene family has a role in spermatogenesis. In view of the marked reduction in Rbm copy number associated with the Y d1 deletion, it was important to establish whether this causes any spermatogenic impairment. Since XY d1 mice are female, we introduced a fully penetrant Sry transgene to generate males with the Y d1 deletion.
We have assessed transcript levels in adult testes and 14.5 dpp testes (when expression is maximal) of these mice by northern analysis. At both ages, Rbm transcripts were barely detectable (Fig. 5) . By using PCR primers specific for the two splice variants identified among cDNA clones, we found that both types of transcripts are produced by these Y d1 males, and sequencing of cloned RT-PCR products established that transcripts with an intact ORF are produced.
The question arises as to whether the reduction in Rbm transcripts in XY d1 Sry males is due to the same position effect that inhibits Sry transcription in the fetal testis, or whether it is due to the reduction in Rbm gene copies. The northern blots in Figure 5 include RNA from XY, XY d1 Sry and XSxr a O males. Although adult XSxr a O males have a meiotic block and consequently almost totally lack spermiogenic stages, at 14.5 dpp when control levels are maximal, XSxr a O males have the same spermatogenic cell complement as normal males (25) . Since in XSxr a O males the Y-derived Sxr a fragment is attached distal to the pseudoautosomal region of the X chromosome, and Sry is transcribed and functions normally, there is no reason to expect inhibition of the Rbm copies due to a position effect. Nevertheless, as seen in Figure 5 , there is a marked reduction in transcript levels compared with controls in both XSxr a O and XY d1 Sry males. We therefore favour the view that Rbm is transcribed from multiple copies, and that the reduced transcript levels in XSxr a O and XY d1 Sry males is, at least in part, due to the reduced gene copy number. Nevertheless, the reduction in XY d1 Sry males as compared with XSxr a O males is greater (by PhophorImager analysis) than that predicted from the relative copy number, suggesting that the position effect that inhibits Sry transcription also plays a part in reducing Rbm transcription.
Recently, we generated a mouse RBM-specific antibody that reacts with spermatogonia, early spermatocytes and elongating spermatids in control testis sections; this staining is abolished by pre-absorbtion with the immunizing peptide (Fig. 6) . In Y d1 males, there is no detectable RBM protein in spermatogonia, but quite strong staining of some elongating spermatid stages is retained; nevertheless, the level of elongating spermatid staining is markedly reduced and more restricted as to stage when compared with controls (Fig. 6) .
Despite the marked reduction in Rbm expression, Y d1 males were fertile, although testis weights and sperm counts were perhaps somewhat lower than expected for outbred mice. To ascertain whether this represents spermatogenic impairment due to the Y d1 deletion, or whether it is associated with the genetic background or some inadequacy of the Sry transgene, we sex-reversed XY tdym1 females, which are deleted for Sry (26) (27) (28) by introducing the same Sry transgene, and then by mating these XY tdym1 Sry males to XY d1 females we produced XY tdym1 Sry and XY d1 Sry sibs for comparison. As can be seen from Table 1, there is no evidence of reduced sperm production in XY d1 Sry males as compared with XY tdym1 Sry males.
Finally, we assessed sperm quality in these two genotypes. This revealed that the Y d1 deletion is associated with a marked increase in abnormal sperm development; 32% of sperm entering the epididymis having grossly distorted heads, and a further 14% have more subtle anomalies ( Fig. 7A and B) . We have found that in normal males and in males with increased levels of abnormal sperm associated with Yq deletions, there is strong selection against abnormal forms during passage through the caput epididymis (M.S., S.K.M. and P.S.B., unpublished). This selection is also seen in XY tdym1 Sry males but, for some reason, there is very little selection against the abnormal sperm in XY d1 Sry males (Fig. 7C) . Mean ± SEM 71 ± 1 106.8 ± 3.0 2859 ± 129 14.6 ± 1.3
DISCUSSION
In this study, we have shown that the previously identified deletion, Y d1 , that is associated with male to female sex reversal due to position effect inibition of Sry transcription (18, and present study), is also associated with a markedly increased incidence of abnormal sperm development when present in XY d1 Sry transgenic males. We have ruled out the possibility that the sperm abnormality is due to some inadequacy of the Sry transgene, so this mouse Y deletion interval now becomes the third to be associated with a spermatogenic defect (29) . The Y d1 deletion, originally described by Capel et al. (20) , is one of a series of deletions that are the result of unequal recombination events between the Y short arm and the short arm-derived factor Sxr a ; these events occur within a region of repeated DNA that includes the 2.6 kb Sx1 repeat (18) . It has been estimated by pulsed-field analysis that the repeating unit containing Figure 6 . Immunocytochemical analysis of RBM protein in control and XY d1 Sry testes. First row: stage XI, I and VII tubules from a control male showing the intense nuclear RBM staining in spermatogonia (stained nuclei in basal layer) and elongating spermatids (XI and I, inner layer). The elongating spermatid staining is absent at stage VII (step 16 spermatids). Second row: stage XI tubule from control male stained with antibody pre-absorbed (PA) with the immunizing peptide, in which only background cytoplasmic staining is seen, and stage X tubules at higher power showing clear RBM staining (cf. pre-absorbed, PA) of zygotene spermatocyte (z) and elongating spermatid (es) nuclei, and weak (not consistently above background) staining of pachytene spermatocyte nuclei (p). Third row: stage XI, I and VII tubules from XY d1 Sry testes showing weakened RBM staining of elongating spermatids and lack of spermatogonial staining. Bottom panel: the changing pattern of RBM staining in spermatid nuclei from testes of (top row) a normal male showing the absence of clear staining in step 4 round spermatids (cf. PA control below), the appearance of staining at step 9, the gradual localization of staining to the post-acrosomal region and the eventual loss of staining by step 16, and (bottom row) the much weaker staining and earlier loss in an XY d1 Sry male (note also the abnormal shape to the back of the head already evident at step 12). The numbers of abnormal sperm by category in a sample of 600 sperm from the initial segment of the caput of three XY d1 Sry and three XY tdym1 Sry males. The 'other' category consists predominantly of degenerating sperm (these are almost completely absent lower down the tract). (C) A comparison of the degree of selection against abnormal sperm during passage down the male tract of the XY d1 Sry and XY tdym1 Sry males (C1, initial segment of the caput epididymis; C2, remainder of the caput epididymis; Cd, cauda epididymis; V, vas deferens). The frequency in caput 1 was equated to 1, and the frequencies lower down the tract were expressed relative to caput 1. In controls, there is a highly significant selection against abnormal forms between caput 1 and caput 2, while in XY d1 Sry males there is a non-significant increase in slightly abnormal sperm between caput 1 and caput 2, and slight selection against grossly abnormal forms (heterogeneity χ 2 s on original numbers: control slightly abnormal, χ 2 = 24.8, P < 0.0005; control grossly abnormal, χ 2 = 14.0, P < 0.0005; XY d1 Sry slightly abnormal, χ 2 = 1.4, P NS; XY d1 Sry grossly abnormal, χ 2 = 3.9, P = 0.05-0.025).
A the 2.6 kb Sx1 repeat is ∼70 kb (Dr Michael Mitchell, personal communication); if there are at least 50 copies on the normal Y (22) and only ∼4 remain in Y d1 (present data), this would make the Y d1 deletion at least 3-4 Mb. We now show that Rbm, the mouse homologue of the human AZF candidate gene RBM, is part of the same repeating unit, making this gene a candidate for providing the spermatogenic function defined by the Y d1 deletion.
How strong is the case supporting Rbm's candidature? Aside from the map position, the case is supported by evolutionary arguments and by the expression analysis. The fact that the Rbm gene family is represented on the Y of mammals from man (9) to marsupial (17) is proof enough that Rbm has a function that engendered sufficient selective pressure for it to be retained on the Y in the face of the attrition that besets genes on this chromosome (2, 30) . If, as it appears, Rbm expression is restricted to the male germ line, then we must conclude that this function is related to spermatogenesis; this need not be a mandatory function, since any improvement in the efficiency of spermatogenesis would be strongly selected for (29, 31) . Thus, there are strong a priori reasons for expecting loss of Rbm expression to be associated with some disturbance of the spermatogenic process.
Our transcription analysis, in agreement with that of Elliot et al. (19) , shows that Rbm is transcribed almost exclusively in the testis and that this testicular transcription is germ cell dependent. The pattern of transcription is, in fact, very similar to that of Ube1y. For both, transcripts are present throughout the development of the fetal testis; post-natally there are high levels in spermatogonia, they all but disappear in pachytene spermatocytes when the X and Y are in a transcriptionally repressed state and they reappear in round spermatids. In our view, these features of Rbm (and Ube1y) expression constitute compelling evidence for a role in the spermatogenic process.
In some respects, it is the mildness and stage of the defects in Y d1 males that are surprising. Rbm is expressed throughout testis development, and some of the strongest expression revealed by the antibody staining is in spermatogonial stages; yet there is no evidence of reduced sperm output in the Y d1 males and they are fertile despite the high incidence of abnormal sperm. The lack of an effect of a nearly complete absence of RBM in spermatogonia may mean that there is redundancy for hnRNP function in the earlier spermatogenic stages. This is supported by the study of Kamma et al. (32) , who found that hnRNPs A1, C, D, F/H, K/J, L and U are all expressed in mouse spermatogonia, all but A1 in spermatocytes, but none is expressed in spermatids. The reactivation of Rbm expression in spermatids may therefore be of particular significance. Indeed, the fertility of Y d1 males may be wholly dependent on the appreciable levels of RBM protein that are retained in the elongating spermatid stages of these mice.
The retention of Rbm expression in spermatids of Y d1 males despite the near extinction of expression in spermatogonia is reminiscent of the situation with Sry which is not transcribed in the embryonic gonad but is transcribed from the Y d1 chromosome in adult XYY d1 testes (18) . This latter transcription is almost certainly in spermatids since this is the predominant source of Sry transcripts in the adult testis (33, 34) . It may be that in both cases this represents an escape from position effect inhibition as a consequence of the chromatin restructuring that occurs during spermatid stages as histones are replaced with protamines. If a position effect is operating to inhibit transcription of Sry and the remaining copies of Rbm on the Y d1 chromosome, it follows that the amplification of Rbm/Sx1 on the normal Y is serving as a 'buffer' to allow Sry and the more distal copies of Rbm to be transcribed.
What is the phenotype associated with RBM deletions in man? Assessing this has been complicated by the presence of some RBM copies outside the AZF deletion interval and by the fact that many of the deletions studied also removed copies of the other AZF candidate DAZ. Recently, evidence has been presented that the only functional copies of RBM are restricted to the AZFb deletion interval (35,36) ; deletion of this interval is associated with azoospermia due to spermatocyte arrest (14) . In agreement with this, two patients studied by Elliot et al. (36) that had these functional RBM copies deleted but were DAZ positive were azoospermic with spermatocyte arrest at the pachytene stage. As in Y d1 mice, the lack of RBM in spermatogonia seems to have no obvious effect on spermatogonial function. However, an arrest at pachytene does not tally with our finding of sperm abnormalities but normal sperm counts in Y d1 males; even without the residual RBM expression seen in elongating spermatids in Y d1 mice, there would seem to be no reason to expect arrest earlier than the round spermatid stage.
Why are the effects of RBM/Rbm deletion different in the two species? A likely answer is provided by the differences in expression pattern apparent from the antibody staining in the two species. In both species, the protein is located predominantly in the nucleus. In man, RBM protein is detected at high levels in spermatogonia, continues to be expressed throughout the primary spermatocyte stages, is clearly detected in round spermatids, but has disappeared by the elongating spermatid stages (36) . By contrast, in the mouse, we have seen that after the strong expression in spermatogonia, RBM expression is extinguished rapidly in spermatocyte stages and does not reappear until elongating spermatid stages. The difference in expression in primary spermatocytes has been corroborated at the level of transcription-in man, RNA in situ hybridization revealed high levels of transcripts in pachytene spermatocytes (37) , while in the mouse few if any Rbm transcripts are present in purified pachytene cells. Thus it is possible that in man RBM provides an essential function during pachytene that is provided by a different hnRNP in the mouse, and that the converse is true for elongating spermatid stages.
It is becoming increasingly clear that there is a distinct lack of concordance with respect to the genes represented on the Y chromosomes of different mammalian species (29) . The present results further suggest that even with a gene such as RBM/Rbm, that is present on the Y of a wide range of mammals, there may be substantial differences in function. This has implications for those who seek to use targeted mutagenesis of Y chromosomal genes in the mouse to provide pointers to the function of the human homologues, and highlights the need for detailed expression studies. Nevertheless, we would argue that the present results do provide further support for the view that many (perhaps all) of the genes on mammalian Y chromosomes that have a predominantly testicular expression pattern are likely to function in spermatogenesis (31) , and the challenge for the future is to define these functions fully.
MATERIALS AND METHODS
Mice
The control Y RIII , the Y RIII short arm derivatives Sxr a (38, 39) and Sxr b (40) , and the Y tdym1 deletion [a 14kb deletion in the short arm which removed Sry (26, 27) ] are maintained at NIMR on a random-bred MF1 (OLAC) background. The Y d series of deletions (18, 20) were generated by B.M.C. at the MRC Radiobiology Unit. XY tdym1 Y d1 mice were produced by mating XY tdym1 Y RIII -del males, that transmit almost exclusively X and Y tdym1 gametes (28) , to XY d1 females which produce X, Y d1 , XY d1 and '0' gametes (20) . To produce males carrying Y d1 , XY d1 females were mated to males carrying the X-linked marker Paf (41) and an Sry transgene derived from the transgenic line C57BL/6Ei-Y AKR/J TgN(Sry-129)2Ei [produced at The Jackson Laboratory by injecting C57BL/6 Y AKR pronuclear stage embryos with the 14 kb Sry-positive genomic clone previously used by Koopman et al. (42) ]. The Paf marker was used to facilitate identification of males who carried the Y d1 chromosome since these were also hemizygous for Paf; the marker subsequently was removed by back-crossing the Y d1 males to MF1 females. XY tdym1 males were produced by introducing the same Sry transgene, once again using the Paf marker for identification. To produce XY d1 Sry and XY tdym1 Sry males in the same litters, XY tdym1 Sry males were mated to XY d1 females.
Sperm analysis
Sperm counts were carried out as described previously (43) except that the sperm sample was derived only from the initial segment of the caput epididymis (up to the third blood vessel). For the analysis of sperm abnormality frequencies in different regions of the male tract, sperm were sampled from three XY d1 Sry males and three XY tdym1 Sry males of each genotype, samples being obtained in each case from the vas deferens, the three regions of the epididymis-'caput 1' (the initial segment), 'caput 2' (the remainder of the caput) and the cauda. Sperm were suspended in phosphate-buffered saline and the suspension was smeared on slides and fixed in 3:1 methanol:acetic acid. Two slides were prepared from each region for each male. The slides were then dipped in 0.4% Photoflo for 2 min, air dried and stained with silver nitrate (44) . Scoring was carried out 'blind' as to genotype using the categories defined by Styrna et al. (45) , but with the addition of an extra class (see 1b in Fig. 7B ). It appeared from the data obtained that there was selection against abnormal forms during passage through the male tract. To assess the degree of selection, the ratios of abnormal to normal sperm were calculated for each region of the tract, the ratio for caput 1 was equated with 1 and the proportion of abnormal sperm remaining in subsequent regions of the tract was calculated relative to caput 1.
Testis cell purification
Testis cell purification was as previously described by Odorisio et al. (23) . Briefly, pachytene spermatocytes (75-80% pure, contaminated predominantly with round and elongated spermatids) and round spermatids (80-85% pure, contaminated predominantly with elongating spermatids) were separated from adult testis cell suspensions by elutriation (46) . Type A spermatogonia (85% pure) and Sertoli cells (90% pure) were isolated from 6 dpp testes using a small StaPut chamber (Johns Scientific) (47) .
Rbm genomic and cDNA clones
Except where stated, routine molecular techniques throughout were as described by Sambrook et al. (48) . Three Rbm-positive genomic clones were obtained by screening a 129/SvEv-GpiI c (49) male genomic library in λ Fix II vector (Stratagene) (24) with the human RBM cDNA clone MK5 (9) . Southern blotting analysis of EcoRI-digested DNA showed that all three clones contained a 6.5 kb MK5-positive EcoRI fragment, while two also contained a 3 kb MK5-positive EcoRI fragment. All the MK5-hybridizing material subsequently was localized to a 3.8 kb BglII fragment that was partially sequenced using a transposon insertion approach (50) to provide multiple entry points for sequencing. Comparison of the sequences obtained with the published sequence of MK5 identified two intron-exon boundaries and enabled the design of PCR primers (see 'Probes and primers') that amplified the predicted 159 bp product from cDNA. This 159 bp product was cloned and sequenced.
Sixteen Rbm cDNA clones were obtained by screening a 17.5 dpp pre-pubertal testis cDNA library [MF1Y RIII strain in which the Y originated from an Sxr a stock (51)] in Uni-ZAPt XR vector (Stratagene) with the 159 bp Rbm fragment. The library was prepared following the manufacturer's instructions using RNA extracted from testis tubules separated from interstitial tissue by treatment with collagenase (0.5 mg/ml) and hyaluronidase (0.5 mg/ml) in HEPES-buffered Dulbecco modified Eagle's medium for 20 min at 32_C, followed by a further 10 min incubation in hyaluronidase. This library is enriched in meiotic and pre-meiotic germ cell cDNAs. The cDNA clones were used to generate mRNAs that were then translated in vitro using nuclease-treated rabbit reticulocyte lysate (Promega) following the manufacturer's instructions.
Sequencing
Automated sequencing of 'transposon' clones derived from the 3.8 kb BglII fragment and the 3′ end of the cDNA clones was carried out using an ABI 373s sequencer with an ABI (Perkin Elmer) Prism Dye Terminator Cycle Sequencing Ready Reaction Kit. To obtain a full sequence for cDNA 8, unidirectional clones produced using the Erase-a-Base system (Promega) were sequenced manually from both strands with the Sequenaset version 2.0 DNA sequencing kit (USB, Amersham Life Sciences).
Probes and primers
For Rbm, (i) a 6.5 kb EcoRI fragment from genomic clone λ7; (ii) LSM15, the 0.3 kb MboI fragment from λ7 (18); (iii) 1.6 kb cDNA 2; and (iv) forward primer 5′ CAAGAAGAGACCACCAT-CCT, reverse primer 5′ CTCCCAGAAGAACTCACATT were used. The probe for actin was a mouse α-actin cDNA 1.15 kb Pst fragment which recognizes α-and β-actin transcripts (52). pSx1 is a 1.8 kb EcoRI fragment mapping to the Sxr b deletion region of the mouse Y short arm (53) , and pYMT2/B is a 1.3 kb Ssty cDNA clone (54) . For Hprt primers, see Koopman et al. (55) 
Southern analysis
Genomic DNA was isolated from tail biopsies (56) . Twelve µg of each DNA was restricted with EcoRI, electrophoresed through a 0.8% agarose gel and transferred to a Hybond N + membrane (Amersham). Membranes were hybridized with 32 P-labelled probes (Prime It kit, Stratagene) and washed at high stringency (0.1× SSC, 0.1% SDS, at 65_C twice for 1 h). When hybridizing the 6.5 kb EcoRI fragment from genomic clone λ7, it was necessary to compete with total mouse male and female genomic DNA to reduce hybridization to repetitive sequences. The filters were exposed to phosphor screens and scanned with a PhosphorImager (Molecular Dynamics) to allow subsequent imaging and quantitation with ImageQuant software (using 'integrate volume' and individual track background). For sequential hybridizations, labelled probes were removed by washing the filters in 50% formamide in 10 mM NaH 2 PO 4 (pH 6.8) at 60_C for 1 h.
Transcriptional analysis
Total RNA was isolated using the AGPC method (57) except for the 6 dpp spermatogonia and Sertoli samples, that were isolated using guanidinium isothiocyanate-caesium chloride (58) . Poly(A) + RNA used for some northern analyses was isolated with a QuickPrep Micro mRNA purification kit (Pharmacia Biotech).
For RT-PCR, 2 µg of total RNA from each tissue was reverse transcribed in a 60 µl reaction using standard procedures. A 2.5 µl aliquot was then added to a 25 µl PCR reaction containing 250 ng of Rbm primers (159 bp product) and 200 ng of Hprt primers (352 bp product). cDNA was amplified for 32 cycles of 20 s at 96_C, 45 s at 54_C and 50 s at 72_C, and with an 8 min extension at 72_C. Products were separated on a 3% agarose gel and stained with ethidium bromide.
For northern blot analysis 2-5 µg of poly(A) + RNA or 10 µg of total RNA, together with RNA size markers, were electrophoresed in a 1.4% agarose gel containing 1.9 M formaldehyde. RNA was transferred to Hybond-N membrane (Amersham) using 20× SSC, and the membrane was hybridized overnight to 32 P-labelled probes (Prime It kit, Stratagene) using 1-2×10 6 c.p.m. of each probe. Filters were washed at 60_C for 30 min in 0.5× SSC, 0.1% SDS, then 30 min in 0.2× SSC, 0.1% SDS and 40 min in 0.1× SSC, 0.1%SDS, and the filters were then exposed to phosphor screens to allow subsequent imaging and quantitation.
RBM immunostaining
Rbm cDNA in Bluescript was digested with BglII and XhoI and the released 1 kb Rbm fragment was subcloned into pET32a (Novagen) digested with BamHI and XhoI. The resulting plasmid (pM4) was transformed into Escherichia coli AD494 (Novagen), and a single polypeptide of 45 kDa was induced on addition of 1 mM isopropyl-β-D-thiogalactopyranoside (IPTG). This polypeptide is a fusion between thioredoxin and RBM. The RBM sequence starts GSATSAQTRS (after the RNA-binding domain) and continues to the end of the protein. The first glycine is converted from an arginine in RBM as a result of the BglII-BamHI ligation. This polypeptide was purified as an inclusion body after cell lysis in 20 mM sodium phosphate/500 mM sodium chloride pH 7.8, and then solubilized in 0.1 M sodium bicarbonate/0.05% SDS pH 9.6. The soluble protein was injected into a rabbit as an emulsion with TitreMax adjuvant (CytRx Corporation, GA, USA). The rabbit was boosted after 7 weeks, and blood collected after a further 2 weeks. Antibodies directed against RBM were purified by affinity selection against the bacterially produced immunizing polypeptide immobilized on an Immobilon filter. Sections were prepared from testes fixed in Bouin picro formol solution and embedded in paraffin wax. Immunostaining was carried out as previously described (36) using a 1:10 dilution of purified antibody. 
